Visante announces alliance with HelioMetrics® to help hospitals and health systems curb rates of opioid drug diversion
Healthcare consulting group and technology firm combine specialized solutions to identify and prevent diversion
MINNEAPOLIS – September 12, 2016 – Visante, Inc. announces an alliance with HelioMetrics, a drug diversion software analytics solution, to provide enhanced services to hospitals and health systems in the U.S. The combined services are an option for hospitals and health systems looking to improve their drug diversion prevention through a comprehensive approach of consulting services and a technology solution.
Drug diversion in hospitals is a critical issue for healthcare as the nation struggles with an epidemic of opioid addiction. Controlled substances, such as oxycodone and fentanyl, are misappropriated from hospitals in a variety of ways and by staff at all levels in the organization. “Addiction is an equal opportunity disease,” explains Greg Burger, VP at Visante. “The alarming rate of prescription opiate use and abuse in the U.S. affects all persons and is reflected inside the walls of the healthcare organization.”
According to a 2010 study by the National Council of State Boards of Nursing, approximately 15% of healthcare staff struggle with drug dependence at some point in their career. “Drug diversion reaches across every area of a hospital or health system, and so it’s critical diversion prevention reaches across the organization,” explains Burger. “Our consulting services identify and mitigate organizational risk areas. We are excited about working with HelioMetrics analytical technology to further improve how hospitals identify diversion activity and accelerate investigations.”
“We are excited about this strategic relationship in order to deliver the value and convenience of HelioMetrics Rx Diversion Analytics through Visante’s extensive network of clients,” says Cherie Mitchell, President of HelioMetrics. “The goal of the partnership is to help clients simplify the complexity of controlled substance diversion investigations.”
Visante is a healthcare consulting firm specializing in medicines management in hospitals and health systems. HelioMetrics Rx Diversion Analytics detects diversion by adding context to the transactions through behavior and providing the information in easy to consume visualizations to help reduce investigation time, strengthen corporate compliance and limit organizational exposure. This helps clients to understand system weaknesses and allow for operational efficiency for quality and patient safety. The alliance will offer a combined approach to the hospital and health systems market, and both companies will continue to offer their services independently.
About Visante
Visante, with offices in the US, Canada and the United Kingdom, provides medicines management consulting to a wide variety of healthcare companies, including hospitals, health systems, managed care organizations, health IT and technology firms, and pharmaceutical manufacturers. Visante helps clients optimize medication use, increasing the quality of patient care and managing costs. Founded in 1999, Visante is comprised of consultants who are pharmacists, doctors, nurses, finance and IT professionals, each with 20 or more years of healthcare experience. Learn more at www.visanteinc.com.
About HelioMetrics
HelioMetrics analytics solutions for healthcare allow for actionable intelligence based on behavioral analysis. HelioMetrics Rx Diversion Analytics provides a comprehensive way to monitor, detect, and investigate drug diversions. Automating controlled substance monitoring provides healthcare organizations enhanced reporting capabilities, while simultaneously reducing the organization’s workload and ability to respond quickly. Learn more at www.heliometrics.net.
Contacts:
Kirsten Galloway (612) 850-0897 or kgalloway@visanteinc.com
Cherie Mitchell (612)444-3249 or cmitchell@heliometrics.net